SCHEMBL2255014

SCHEMBL2255014

O=C(O)c1ccc(-c2ccc(F)cc2)cc1C=CCCCc1ccc2cc(O)ccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.46
BAD Q92934 1/20 0.46
RARB P10826 3/20 0.40
RARA P10276 1/20 0.40
RARG P13631 1/20 0.40
HCAR2 Q8TDS4 5/20 0.40
PPARA Q07869 1/20 0.36
STING1 Q86WV6 1/20 0.36
AKR1B10 O60218 1/20 0.36
AKR1A1 P14550 1/20 0.36
AKR1B1 P15121 1/20 0.36
CBR1 P16152 1/20 0.36
AKR1C4 P17516 1/20 0.36
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
AKR1C1 Q04828 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TOP2A P11388 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2255008 1.00 BCL2L1 (0.46) BCL2L1BADRARBRARARARG
SCHEMBL2256080 0.94 BCL2L1 (0.47) BCL2L1BADRARBRARARARG
SCHEMBL2256074 0.94 BCL2L1 (0.47) BCL2L1BADRARBRARARARG
SCHEMBL2254597 0.87 BCL2L1 (0.49) BCL2L1BADRARBRARARARG
SCHEMBL2254605 0.87 BCL2L1 (0.49) BCL2L1BADRARBRARARARG
SCHEMBL2255006 0.81 RARB (0.47) RARBRARARARGHCAR2PPARA
SCHEMBL2255122 0.81 RARB (0.44) RARBRARARARGHCAR2PPARA
SCHEMBL2255160 0.80 RARB (0.49) RARBRARARARGHCAR2PPARA
SCHEMBL2254854 0.78 EGFR (0.47) RARBRARARARGHCAR2PPARA
SCHEMBL2254661 0.78 BCL2L1 (0.66) BCL2L1BADHCAR2TOP2ATOP2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904047-B1 APOPTOSIS PROMOTERS ABBOTT LAB (US) 2013-01-02 EP disclosed
US-7989656-B2 Biaryl carboxylic acid apoptosis promoters ABBOTT LABORATORIES (US) 2011-08-02 US disclosed
US-20100234456-A1 APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2010-09-16 US disclosed
US-7750004-B2 Apoptosis promoters ABBOTT LABORATORIES (US) 2010-07-06 US disclosed
US-20070135392-A1 Apoptosis promoters ABBVIE INC. 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234456-A1 APOPTOSIS PROMOTERS MCL1, BAX, BCL2 BCL2L1 5/4885BAD 11/4885RARB 1484/4885
US-20070135392-A1 Apoptosis promoters MCL1, BAX, BCL2 BCL2L1 5/4885BAD 11/4885RARB 1484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.